Log in to search using one of your social media accounts:

FY17National Lupus Outreach and Clinical Trial Education Program
Funding Opportunity ID: 289374 Opportunity Number: MP-CPI-17-002 Opportunity Title: FY17National Lupus Outreach and Clinical Trial Education ProgramOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.137Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Eligible Applicants. State governments County Governments Special district governments Public and State controlled institutions of hi...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

FY17National Lupus Outreach and Clinical Trial Education Program
Funding Opportunity ID: 289374 Opportunity Number: MP-CPI-17-002 Opportunity Title: FY17National Lupus Outreach and Clinical Trial Education ProgramOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.137Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Eligible Applicants. State governments County Governments Special district governments Public and State controlled institutions of hi...
Source: Grants.gov - December 31, 2016 Category: Research Tags: Health Source Type: funding

Advanced Biomanufacturing of Therapeutic Cells (ABTC)
Preliminary Proposal Deadline Date: January 4, 2017 Preliminary Proposal Submission Deadline Program Guidelines: NSF 17-502In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, ...More at ...
Source: NSF Upcoming Due Dates - December 5, 2016 Category: Science Source Type: funding

Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Funding Opportunity Number: RFA-OH-16-008 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.262Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with th...
Source: Grants.gov - March 9, 2016 Category: Research Tags: Health Source Type: funding

Cooperative Study Group for Autoimmune Disease Prevention (U01)
Funding Opportunity Number: RFA-AI-16-003 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status w...
Source: Grants.gov - February 25, 2016 Category: Research Tags: Health Source Type: funding

Cooperative Study Group for Autoimmune Disease Prevention (U01)
Funding Opportunity RFA-AI-16-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications from institutions or consortia of institutions to participate in a cooperative study group focused on prevention of human autoimmune disease. The ultimate goal of the FOA is to develop the knowledge base necessary to design selective preventive interventions that could be administered efficiently and safely to the general population or to individuals at risk of autoimmune disease, including infants and children. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2016 Category: Research Source Type: funding

Michigan Lupus Epidemiology and Surveillance (MILES) Program Longitudinal Cohort Study
Funding Opportunity Number: RFA-DP-16-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.283Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Feb 05, 2016Award Ceiling: $1,000,000Expected Number of Awards: 1Creation Date: Dec 07, 2015Funding Opportunity Description: Lupus is a prototypical autoimmune disease with a wide spectrum of illness that can be limited to the skin or can affect almost any tissue and org...
Source: Grants.gov - December 8, 2015 Category: Research Tags: Health Source Type: funding

Human Immunology Project Consortium (U19)
Funding Opportunity Number: RFA-AI-15-041 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status w...
Source: Grants.gov - November 21, 2015 Category: Research Tags: Health Source Type: funding

Human Immunology Project Consortium (U19)
Funding Opportunity RFA-AI-15-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) on the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, adjuvants or natural infection by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will measure th...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2015 Category: Research Source Type: funding

Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships
Funding Opportunity Number: CDC-RFA-DP15-1511 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.06893.13593.328Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3...
Source: Grants.gov - June 12, 2015 Category: Research Tags: Health Source Type: funding

Call for Applications: James T. Lubin Clinician Scientist Fellowship Award
The objective is to provide salary and research support for 2 years of post-doctoral training to ensure a future of well-trained clinician-scientists focused on rare neuro-immune diseases. The total salary requested must be based on a full-time, 12-month staff appointment. Funds may be used to support tuition and fees related to career development, research expenses, such as supplies, equipment and technical personnel and travel to research meetings or training. Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are not reimbursed by The TMA. Eligibility and Additional Guidelines 1. Applic...
Source: ScanGrants feed - November 19, 2014 Category: Research Authors: Transverse Myelitis Association Source Type: funding

National Blood Foundation Scientific Research Grants Program
Submit the application by 11:59pm ET December 31, 2014. Application fee of $150 must accompany the application unless the primary investigator is an AABB individual member. The National Blood Foundation annually awards grants for one or two-year research projects, with a maximum award per grant of $75,000. NBF is pleased to announce the availability of funding in 2015 for scientific research projects related to transfusion medicine and cellular therapies. NBF will award grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood ma...
Source: ScanGrants feed - August 25, 2014 Category: Research Authors: National Blood Foundation Source Type: funding

Call for Applications: Research Seed Money Grant for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1)
National Organization for Rare Disorders (NORD), with APS Type 1.org, Announces Research Seed Money Grant (up to $100,000) for APS Type 1 (Autoimmune Polyglandular Syndrome Type 1) Abstract Submission Deadline:  July 10, 2014 NORD, with funding raised in coordination with the patient organization, , is accepting applications for a two-year grant, for a total of $100,000, to conduct a scientific and/or clinical research study related to APS Type 1. Also known as autoimmune polyglandular syndrome, type 1, APS Type 1 is a very rare hereditary disorder that strikes children and adults younger than 35 years of age. ...
Source: ScanGrants feed - June 24, 2014 Category: Research Authors: National Organization for Rare Disorders/APS Type 1.Org Source Type: funding

2014 ASPIRE Rheumatology and Dermatology Research Awards
As competition for research funding increases, the ASPIRE program underscores Pfizer's commitment to supporting research in autoimmune diseases within rheumatology and dermatology. Mission The mission of the 2014 ASPIRE program is to support basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the epidemiology, pathogenesis and treatment of selected diseases. The ASPIRE Program demonstrates Pfizer’s commitment to supporting promising investigators with an interest in advancing knowledge in defined disease areas within rheumatology ...
Source: ScanGrants feed - June 17, 2014 Category: Research Authors: Pfizer Source Type: funding

FY14 National Health Education Program on Lupus for Healthcare Providers
Funding Opportunity Number: MP-CPI-14-001 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.137Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-OPHSClosing Date: Jun 09, 2014Award Ceiling: $2,000,000Expected Number of Awards: 1Creation Date: Apr 16, 2014Funding Opportunity Description: The purpose of the NHEPLHP is to eliminate lupus related health disparities among racial and ethnic minority populations disproportionately affected by this disease. This ...
Source: Grants.gov - April 17, 2014 Category: Research Tags: Health Source Type: funding

NIAID Division of Allergy, Immunology and Transplantation: Statistical and Clinical Coordinating Center (UM2)
Funding Opportunity Number: RFA-AI-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status w...
Source: Grants.gov - March 27, 2014 Category: Research Tags: Health Source Type: funding

NIAID Division of Allergy, Immunology and Transplantation: Statistical and Clinical Coordinating Center (UM2)
Funding Opportunity RFA-AI-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Statistical and Clinical Coordinating Center, NIAID Division of Allergy, Immunology and Transplantation. The awardee will provide a broad range of support critical for the design, development, implementation, monitoring and analysis of clinical research carried out by multiple Division-supported programs in three disease areas: asthma and allergic diseases, autoimmune diseases, and transplantation. The scope of support to be provided includes statistical design and analysis, protocol ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 26, 2014 Category: Research Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity Number: RFA-AR-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) st...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity Number: RFA-AR-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) st...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity RFA-AR-14-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity RFA-AR-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Research Sites. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NIH Fund...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

Call for Applications: Iacocca Family Foundation to Support Innovative and Promising Research Projects on Type 1 Diabetes
Grant Amounts and Number of Grants The Foundation is very focused in its’ grant-making by making a few research grants a year.  Accordingly, the Foundation will consider grants ranging in amounts of $10,000 to $500,000. For calendar year 2014, the Iacocca Family Foundation will accept grant applications to support innovative and promising research projects that will lead to a cure for type 1 diabetes.  The Foundation will accept novel projects which directly accelerate a cure for type 1 diabetes or inform the understanding of the disease by a related or complementary mechanism of action.  Invest...
Source: ScanGrants feed - December 31, 2013 Category: Research Authors: Iacocca Family Foundation Source Type: funding

Call for Applications: 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases
Call for Applications: 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases New Award Available for 2014—Apply by December 13, 2013 The Dermatology Foundation is pleased to introduce a new three-year research award made possible by a generous contribution from Charles and Daneen Stiefel—the 2014 Charles & Daneen Stiefel Scholar Award in Autoimmune &/or Connective Tissue Diseases. This award is designed to support outstanding investigators committed to elucidate the basis, pathophysiology, clinical manifestations, and/or treatment of autoimmune and/or co...
Source: ScanGrants feed - November 19, 2013 Category: Research Authors: Dermatology Foundation Source Type: funding

Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research
Mission The mission of the 2013 ASPIRE Awards in Adult Vaccine Research is to advance medical knowledge to better understand the burden of pneumococcal disease in adults. The burden of pneumococcal disease in the general adult population has been extensively studied; however, it is not well-defined in special populations, including subgroups with underlying disease comorbidities and/or those living in long-term community settings. Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals for evaluation of the epidemiology and burd...
Source: ScanGrants feed - May 1, 2013 Category: Research Authors: Pfizer Source Type: funding

Call for Travel Fellowship Applications: Progressive Multifocal Leukoencephalopathy
June 19 - 20, 2013 The New York Academy of Sciences Presented by the Progressive Multifocal Leukoencephalopathy Consortium and The New York Academy of Sciences Progressive Multifocal Leukoencephalopathy (PML) is, in the general population, a rare but serious demyelinating disease of the brain, often resulting in severe disability or death and is caused by infection of oligodendrocytes by the JC polyomavirus (JCV). It is believed that fifty to sixty percent of the population is sero-positive for JCV, indicating exposure to the virus. Despite the high prevalence of JCV infection in the human population, which typicall...
Source: ScanGrants feed - February 6, 2013 Category: Research Authors: Progressive Multifocal Leukoencephalopathy Consortium/New York Academy of Sciences Source Type: funding

Autoimmunity Centers of Excellence, Clinical Research Program (UM1)
Funding Opportunity Number: RFA-AI-12-059 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status w...
Source: Grants.gov - January 16, 2013 Category: Research Tags: Health Source Type: funding

Autoimmunity Centers of Excellence, Basic Research Program (U19)
Funding Opportunity Number: RFA-AI-12-060 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status w...
Source: Grants.gov - January 16, 2013 Category: Research Tags: Health Source Type: funding

Autoimmunity Centers of Excellence, Basic Research Program (U19)
Funding Opportunity RFA-AI-12-060 from the NIH Guide for Grants and Contracts. This FOA solicits applications to participate in the Autoimmunity Centers of Excellence (ACE) program, a cooperative network intended to improve the understanding and treatment of autoimmune diseases (www.autoimmunitycenters.org).The ACE program was founded on the premise that collaboration among basic and clinical scientists can accelerate both fundamental and applied research.For this reissued FOA, the formerly integrated Centers are divided into Basic and Clinical research programs.This FOA solicits applications for the Basic research prog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 15, 2013 Category: Research Source Type: funding

Autoimmunity Centers of Excellence, Clinical Research Program (UM1)
Funding Opportunity RFA-AI-12-059 from the NIH Guide for Grants and Contracts. This FOA solicits applications to participate in the Autoimmunity Centers of Excellence (ACE) program, a cooperative network intended to improve the understanding and treatment of autoimmune diseases (www.autoimmunitycenters.org). The ACE program was founded on the premise that collaboration among basic and clinical scientists can accelerate both fundamental and applied research. For this reissuanc, the formerly integrated Centers are divided into Basic and Clinical research programs. This FOA solicits applications for the Clinical research p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 15, 2013 Category: Research Source Type: funding